Avraham Gabay is Chief Financial Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 0 shares of ORMP, which is worth approximately $0. The most recent transaction as insider was on Jun 21, 2024, when has been sold 140,040 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Avraham Gabay Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2024
BUY
Grant, award, or other acquisition
-
140,040 Added 100.0%
0 Common Stock
AG

Avraham Gabay

Chief Financial Officer
Jerusalem, L3

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP